Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Quan H, Zhang H, Zou L, Yuan W, Wang S. Comparison of outcomes between patients with de-novo sinonasal squamous cell carcinoma vs malignant transformations from inverted papillomas. Int Forum Allergy Rhinol 2020;10:762-767. [PMID: 32216167 DOI: 10.1002/alr.22556] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Revised: 01/08/2020] [Accepted: 02/11/2020] [Indexed: 02/03/2023]

For:	Quan H, Zhang H, Zou L, Yuan W, Wang S. Comparison of outcomes between patients with de-novo sinonasal squamous cell carcinoma vs malignant transformations from inverted papillomas. Int Forum Allergy Rhinol 2020;10:762-767. [PMID: 32216167 DOI: 10.1002/alr.22556] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Revised: 01/08/2020] [Accepted: 02/11/2020] [Indexed: 02/03/2023]

Number

Cited by Other Article(s)

Fan D, Zhu Y, Yang J, Hou J. Global research on sinonasal inverted papilloma over the past two decades: a bibliometric analysis. ACTA OTORHINOLARYNGOLOGICA ITALICA : ORGANO UFFICIALE DELLA SOCIETA ITALIANA DI OTORINOLARINGOLOGIA E CHIRURGIA CERVICO-FACCIALE 2024;44:83-90. [PMID: 38165205 DOI: 10.14639/0392-100x-n2522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Accepted: 07/15/2023] [Indexed: 01/03/2024]

Kuan EC, Wang EW, Adappa ND, Beswick DM, London NR, Su SY, Wang MB, Abuzeid WM, Alexiev B, Alt JA, Antognoni P, Alonso-Basanta M, Batra PS, Bhayani M, Bell D, Bernal-Sprekelsen M, Betz CS, Blay JY, Bleier BS, Bonilla-Velez J, Callejas C, Carrau RL, Casiano RR, Castelnuovo P, Chandra RK, Chatzinakis V, Chen SB, Chiu AG, Choby G, Chowdhury NI, Citardi MJ, Cohen MA, Dagan R, Dalfino G, Dallan I, Dassi CS, de Almeida J, Dei Tos AP, DelGaudio JM, Ebert CS, El-Sayed IH, Eloy JA, Evans JJ, Fang CH, Farrell NF, Ferrari M, Fischbein N, Folbe A, Fokkens WJ, Fox MG, Lund VJ, Gallia GL, Gardner PA, Geltzeiler M, Georgalas C, Getz AE, Govindaraj S, Gray ST, Grayson JW, Gross BA, Grube JG, Guo R, Ha PK, Halderman AA, Hanna EY, Harvey RJ, Hernandez SC, Holtzman AL, Hopkins C, Huang Z, Huang Z, Humphreys IM, Hwang PH, Iloreta AM, Ishii M, Ivan ME, Jafari A, Kennedy DW, Khan M, Kimple AJ, Kingdom TT, Knisely A, Kuo YJ, Lal D, Lamarre ED, Lan MY, Le H, Lechner M, Lee NY, Lee JK, Lee VH, Levine CG, Lin JC, Lin DT, Lobo BC, Locke T, Luong AU, Magliocca KR, Markovic SN, Matnjani G, McKean EL, Meço C, Mendenhall WM, Michel L, Na'ara S, Nicolai P, Nuss DW, Nyquist GG, Oakley GM, Omura K, Orlandi RR, Otori N, Papagiannopoulos P, Patel ZM, Pfister DG, Phan J, Psaltis AJ, Rabinowitz MR, Ramanathan M, Rimmer R, Rosen MR, Sanusi O, Sargi ZB, Schafhausen P, Schlosser RJ, Sedaghat AR, Senior BA, Shrivastava R, Sindwani R, Smith TL, Smith KA, Snyderman CH, Solares CA, Sreenath SB, Stamm A, Stölzel K, Sumer B, Surda P, Tajudeen BA, Thompson LDR, Thorp BD, Tong CCL, Tsang RK, Turner JH, Turri-Zanoni M, Udager AM, van Zele T, VanKoevering K, Welch KC, Wise SK, Witterick IJ, Won TB, Wong SN, Woodworth BA, Wormald PJ, Yao WC, Yeh CF, Zhou B, Palmer JN. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors. Int Forum Allergy Rhinol 2024;14:149-608. [PMID: 37658764 DOI: 10.1002/alr.23262] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 08/24/2023] [Indexed: 09/05/2023]

Abstract

BACKGROUND

Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology-based topics spanning the field.

METHODS

In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence-Based Review with Recommendations, Evidence-Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses format, and completed sections underwent a thorough and iterative consensus-building process. The final document underwent rigorous synthesis and review prior to publication.

RESULTS

The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology-based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.

CONCLUSION

As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.

Collapse

Affiliation(s)

Edward C Kuan Departments of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA
Eric W Wang Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Nithin D Adappa Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Daniel M Beswick Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
Nyall R London Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Shirley Y Su Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Marilene B Wang Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
Waleed M Abuzeid Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Borislav Alexiev Department of Pathology, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, Illinois, USA
Jeremiah A Alt Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Paolo Antognoni Division of Radiation Oncology, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Michelle Alonso-Basanta Department of Radiation Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA
Pete S Batra Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Mihir Bhayani Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Diana Bell Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA
Manuel Bernal-Sprekelsen Otorhinolaryngology Department, Surgery and Medical-Surgical Specialties Department, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
Christian S Betz Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Jean-Yves Blay Department of Medical Oncology, Centre Léon Bérard, UNICANCER, Université Claude Bernard Lyon I, Lyon, France
Benjamin S Bleier Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA
Juliana Bonilla-Velez Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Claudio Callejas Department of Otolaryngology, Pontificia Universidad Católica de Chile, Santiago, Chile Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Ricardo L Carrau Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Roy R Casiano Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Paolo Castelnuovo Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Rakesh K Chandra Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Vasileios Chatzinakis Department of Head, Neck and Skull Base Surgery, Hygeia Hospital, Athens, Greece
Simon B Chen Department of Pathology, Stanford University, Stanford, California, USA
Alexander G Chiu Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA
Garret Choby Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
Naweed I Chowdhury Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Martin J Citardi Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Marc A Cohen Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Roi Dagan Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida, USA
Gianluca Dalfino Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Iacopo Dallan Department of Otolaryngology-Head and Neck Surgery, Pisa University Hospital, Pisa, Italy
Camila Soares Dassi São Paulo ENT Center (COF), Edmundo Vasconcelos Complex, São Paulo, Brazil
John de Almeida Department of Otolaryngology-Head and Neck Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada
Angelo P Dei Tos Section of Pathology, Department of Medicine, University of Padua, Padua, Italy
John M DelGaudio Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Charles S Ebert Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Ivan H El-Sayed Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Jean Anderson Eloy Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA
James J Evans Department of Neurological Surgery and Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Christina H Fang Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine, Bronx, New York, USA
Nyssa F Farrell Department of Otolaryngology-Head and Neck Surgery, Washington University in St. Louis, St. Louis, Missouri, USA
Marco Ferrari Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy
Nancy Fischbein Department of Radiology, Stanford University, Stanford, California, USA
Adam Folbe Department of Otolaryngology-Head and Neck Surgery, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA
Wytske J Fokkens Department of Otorhinolaryngology, Amsterdam UMC, Amsterdam, The Netherlands
Meha G Fox Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA
Valerie J Lund Ear Institute, University College London, London, UK
Gary L Gallia Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Paul A Gardner Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Mathew Geltzeiler Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA
Christos Georgalas Department of Otorhinolaryngology-Head and Neck Surgery, University of Nicosia Medical School, Nicosia, Cyprus
Anne E Getz Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, USA
Satish Govindaraj Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Stacey T Gray Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
Jessica W Grayson Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
Bradley A Gross Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Jordon G Grube Department of Otolaryngology-Head and Neck Surgery, Albany Medical Center, Albany, New York, USA
Ruifeng Guo Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
Patrick K Ha Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Ashleigh A Halderman Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Ehab Y Hanna Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Richard J Harvey Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of South Wales, Sydney, New South Wales, Australia
Stephen C Hernandez Department of Otolaryngology-Head and Neck Surgery, LSU Health Sciences Center, New Orleans, Louisiana, USA
Adam L Holtzman Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida, USA
Claire Hopkins Department of Otolaryngology-Head and Neck Surgery, Guys and St Thomas' Hospital, London, UK
Zhigang Huang Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
Zhenxiao Huang Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
Ian M Humphreys Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
Peter H Hwang Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
Alfred M Iloreta Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Masaru Ishii Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Michael E Ivan Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Aria Jafari Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA
David W Kennedy Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Mohemmed Khan Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Adam J Kimple Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Todd T Kingdom Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, USA
Anna Knisely Department of Otolaryngology, Head and Neck Surgery, Swedish Medical Center, Seattle, Washington, USA
Ying-Ju Kuo Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan
Devyani Lal Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
Eric D Lamarre Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Ming-Ying Lan Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Hien Le Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia
Matt Lechner UCL Division of Surgery and Interventional Science and UCL Cancer Institute, University College London, London, UK
Nancy Y Lee Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Jivianne K Lee Department of Head and Neck Surgery, University of California, Los Angeles David Geffen School of Medicine, Los Angeles, California, USA
Victor H Lee Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Corinna G Levine Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Jin-Ching Lin Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan
Derrick T Lin Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA
Brian C Lobo Department of Otolaryngology-Head and Neck Surgery, University of Florida, Gainesville, Florida, USA
Tran Locke Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA
Amber U Luong Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Kelly R Magliocca Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
Svetomir N Markovic Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA
Gesa Matnjani Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Erin L McKean Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA
Cem Meço Department of Otorhinolaryngology, Head and Neck Surgery, Ankara University Medical School, Ankara, Turkey Department of Otorhinolaryngology Head and Neck Surgery, Salzburg Paracelsus Medical University, Salzburg, Austria
William M Mendenhall Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, Florida, USA
Loren Michel Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Shorook Na'ara Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA
Piero Nicolai Section of Otorhinolaryngology-Head and Neck Surgery, Department of Neurosciences, University of Padua, Padua, Italy
Daniel W Nuss Department of Otolaryngology-Head and Neck Surgery, LSU Health Sciences Center, New Orleans, Louisiana, USA
Gurston G Nyquist Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Gretchen M Oakley Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Kazuhiro Omura Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan
Richard R Orlandi Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA
Nobuyoshi Otori Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan
Peter Papagiannopoulos Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Zara M Patel Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
David G Pfister Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Jack Phan Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Alkis J Psaltis Department of Otolaryngology-Head and Neck Surgery, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Mindy R Rabinowitz Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Murugappan Ramanathan Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Ryan Rimmer Department of Otolaryngology-Head and Neck Surgery, Yale University, New Haven, Connecticut, USA
Marc R Rosen Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Olabisi Sanusi Department of Neurosurgery, Oregon Health and Science University, Portland, Oregon, USA
Zoukaa B Sargi Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Philippe Schafhausen Department of Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Rodney J Schlosser Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
Ahmad R Sedaghat Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Brent A Senior Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Raj Shrivastava Department of Neurosurgery and Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Raj Sindwani Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA
Timothy L Smith Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon, USA
Kristine A Smith Department of Otolaryngology-Head and Neck Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
Carl H Snyderman Departments of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA
C Arturo Solares Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Satyan B Sreenath Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, Indiana, USA
Aldo Stamm São Paulo ENT Center (COF), Edmundo Vasconcelos Complex, São Paulo, Brazil
Katharina Stölzel Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Baran Sumer Department of Otolaryngology-Head and Neck Surgery, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
Pavol Surda Department of Otolaryngology-Head and Neck Surgery, Guys and St Thomas' Hospital, London, UK
Bobby A Tajudeen Department of Otorhinolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
Lester D R Thompson Head and Neck Pathology Consultations, Woodland Hills, California, USA
Brian D Thorp Department of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Charles C L Tong Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Raymond K Tsang Department of Otolaryngology-Head and Neck Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Justin H Turner Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Mario Turri-Zanoni Division of Otorhinolaryngology, Department of Biotechnology and Life Sciences, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
Aaron M Udager Department of Pathology, Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA
Thibaut van Zele Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium
Kyle VanKoevering Department of Otolaryngology-Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
Kevin C Welch Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Sarah K Wise Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia, USA
Ian J Witterick Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
Tae-Bin Won Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
Stephanie N Wong Division of Otorhinolaryngology, Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Bradford A Woodworth Department of Otolaryngology-Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
Peter-John Wormald Department of Otolaryngology-Head and Neck Surgery, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
William C Yao Department of Otorhinolaryngology-Head & Neck Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
Chien-Fu Yeh Department of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
Bing Zhou Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology-Head and Neck Surgery, Ministry of Education, Beijing, China
James N Palmer Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

Collapse

Park MJ, Cho W, Kim JH, Chung YS, Jang YJ, Yu MS. Preoperative Prediction of Sinonasal Inverted Papilloma-associated Squamous Cell Carcinoma (IP-SCC). Laryngoscope 2023;133:2502-2510. [PMID: 36683553 DOI: 10.1002/lary.30583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 12/28/2022] [Accepted: 01/06/2023] [Indexed: 01/24/2023]

Abstract

INTRODUCTION

Sinonasal inverted papillomas (IP) can undergo transformation into IP-squamous cell carcinomas (IP-SCC). More aggressive treatment plan should be established when IP-SCC is suspected. Nevertheless, inaccuracy of the preoperative punch biopsy results to detect IP-SCC from IP raises the need for an additional strategy. The present study aimed to investigate significant clinicoradiological remarks associated with IP-SCC than IP.

MATERIAL AND METHODS

Postoperative surgical specimens obtained from patients with confirmed IP or IP-SCC at a single tertiary medical center from 1997 to 2018 were retrospectively evaluated. Patients' demographic and clinical characteristics, preoperative in-office punch biopsy results, and preoperative computed tomography (CT) or magnetic resonance images were reviewed. Univariate and multivariate analyses were performed to assess the odds ratio (OR) associated with IP-SCC. The area under the curve (AUC) in the receiver Operating Characteristic (ROC) curve was calculated in the prediction model to discriminate IP-SCC from IP.

RESULTS

The study included 44 IP-SCC and 301 patients with IP. The diagnostic sensitivity of in-office punch biopsy to detect IP-SCC was 70.7%. Multivariate analysis showed that factors significantly associated with IP-SCC included tobacco smoking >10PY (adjusted-OR [aOR]: 4.1), epistaxis (aOR: 3.4), facial pain (aOR: 4.2), bony destruction (aOR: 37.6), bony remodeling (aOR: 36.3), and invasion of adjacent structures (aOR: 31.6) (all p < 0.05). Combining all significantly related clinicoradiological features, the ability to discriminate IP-SCC from IP reached an AUC of 0.974.

CONCLUSION

IP patients with a history of tobacco smoking, facial pain, epistaxis, and bony destruction, remodeling, or invasion of an adjacent structure on preoperative images may be at higher risk for IP-SCC.

LEVEL OF EVIDENCE

3 Laryngoscope, 133:2502-2510, 2023.

Collapse

Lin M, Lin N, Yu S, Sha Y, Zeng Y, Liu A, Niu Y. Automated Prediction of Early Recurrence in Advanced Sinonasal Squamous Cell Carcinoma With Deep Learning and Multi-parametric MRI-based Radiomics Nomogram. Acad Radiol 2023;30:2201-2211. [PMID: 36925335 DOI: 10.1016/j.acra.2022.11.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2022] [Revised: 11/12/2022] [Accepted: 11/13/2022] [Indexed: 03/16/2023]

Abstract

RATIONALE AND OBJECTIVES

Preoperative prediction of the recurrence risk in patients with advanced sinonasal squamous cell carcinoma (SNSCC) is critical for individualized treatment. To evaluate the predictive ability of radiomics signature (RS) based on deep learning and multiparametric MRI for the risk of 2-year recurrence in advanced SNSCC.

MATERIALS AND METHODS

Preoperative MRI datasets were retrospectively collected from 265 SNSCC patients (145 recurrences) who underwent preoperative MRI, including T2-weighted (T2W), contrast-enhanced T1-weighted (T1c) sequences and diffusion-weighted (DW). All patients were divided into 165 training cohort and 70 test cohort. A deep learning segmentation model based on VB-Net was used to segment regions of interest (ROIs) for preoperative MRI and radiomics features were extracted from automatically segmented ROIs. Least absolute shrinkage and selection operator (LASSO) and logistic regression (LR) were applied for feature selection and radiomics score construction. Combined with meaningful clinicopathological predictors, a nomogram was developed and its performance was evaluated. In addition, X-title software was used to divide patients into high-risk or low-risk early relapse (ER) subgroups. Recurrence-free survival probability (RFS) was assessed for each subgroup.

RESULTS

The radiomics score, T stage, histological grade and Ki-67 predictors were independent predictors. The segmentation models of T2WI, T1c, and apparent diffusion coefficient (ADC) sequences achieved Dice coefficients of 0.720, 0.727, and 0.756, respectively, in the test cohort. RS-T2, RS-T1c and RS-ADC were derived from single-parameter MRI. RS-Combined (combined with T2WI, T1c, and ADC features) was derived from multiparametric MRI and reached area under curve (AUC) and accuracy of 0.854 (0.749-0.927) and 74.3% (0.624-0.840), respectively, in the test cohort. The calibration curve and decision curve analysis (DCA) illustrate its value in clinical practice. Kaplan-Meier analysis showed that the 2-year RFS rate for low-risk patients was significantly greater than that for high-risk patients in both the training and testing cohorts (p < 0.001).

CONCLUSION

Automated nomograms based on multi-sequence MRI help to predict ER in SNSCC patients preoperatively.

Collapse

Birkenbeuel J, Goshtasbi K, Adappa N, Palmer J, Tong C, Kuan E. Recurrence rates of de-novo versus inverted papilloma-transformed sinonasal squamous cell carcinoma: a meta-analysis. Rhinology 2022;60:402-410. [DOI: 10.4193/rhin22.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]

Lin N, Yu S, Lin M, Shi Y, Chen W, Xia Z, Cheng Y, Sha Y. A Clinical-Radiomics Nomogram Based on the Apparent Diffusion Coefficient (ADC) for Individualized Prediction of the Risk of Early Relapse in Advanced Sinonasal Squamous Cell Carcinoma: A 2-Year Follow-Up Study. Front Oncol 2022;12:870935. [PMID: 35651794 PMCID: PMC9149576 DOI: 10.3389/fonc.2022.870935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Accepted: 04/19/2022] [Indexed: 11/30/2022] Open

Abstract

Purpose

To develop and validate a nomogram model combining radiomic features and clinical characteristics to preoperatively predict the risk of early relapse (ER) in advanced sinonasal squamous cell carcinomas (SNSCCs).

Methods

A total of 152 SNSCC patients (clinical stage III-IV) who underwent diffusion-weighted imaging (DWI) were included in this study. The training cohort included 106 patients assessed at the headquarters of our hospital using MR scanner 1. The testing cohort included 46 patients assessed at the branch of our hospital using MR scanner 2. Least absolute shrinkage and selection operator (LASSO) regression was applied for feature selection and radiomic signature (radscore) construction. Multivariable logistic regression analysis was applied to identify independent predictors. The performance of the model was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curve and decision curve analysis (DCA). Furthermore, the patients were classified into high- or low-risk ER subgroups according to the optimal cutoff value of the nomogram using X-tile. The recurrence-free survival probability (RFS) of each subgroup was assessed.

Results

ER was noted in 69 patients. The radscore included 8 selected radiomic features. The radscore, T stage and surgical margin were independent predictors. The nomogram showed better performance (AUC = 0.92) than either the radscore or the clinical factors in the training cohort (P < 0.050). In the testing cohort, the nomogram showed better performance (AUC = 0.92) than the clinical factors (P = 0.016) and tended to show better performance than the radscore (P = 0.177). The nomogram demonstrated good calibration and clinical utility. Kaplan-Meier analysis showed that the 2-year RFS rate for low-risk patients was significantly greater than that for high-risk patients in both the training and testing cohorts (P < 0.001).

Conclusions

The ADC-based radiomic nomogram model is potentially useful in predicting the risk of ER in advanced SNSCCs.

Collapse

Birkenbeuel JL, Pang JC, Lee A, Nguyen ES, Risbud A, Goshtasbi K, Abiri A, Lehrich BM, Tong CCL, Adappa ND, Palmer JN, Kuan EC. Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review. Head Neck 2022;44:1014-1029. [PMID: 35141984 DOI: 10.1002/hed.26995] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 11/03/2021] [Accepted: 01/24/2022] [Indexed: 12/30/2022] Open

Nguyen ES, Risbud A, Birkenbeuel JL, Murphy LS, Goshtasbi K, Pang JC, Abiri A, Lehrich BM, Haidar YM, Tjoa T, Kuan EC. Prognostic Factors and Outcomes of De Novo Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2021;166:434-443. [PMID: 34253092 DOI: 10.1177/01945998211021023] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]